Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality
worldwide. Effective prevention and management strategies are essential to reduce the …

Cardiac diseases form the lion's share of the global disease burden, owing to the paradigm
shift to non-infectious diseases from infectious ones. The prevalence of CVDs has nearly …

Multifactorial risk factor modification and control, espe-cially interventions designed to
reduce total cholesterol, systolic blood pressure, smoking prevalence, overweight/obesity …

Background: Secondary prevention lifestyle and pharmacological treatment of
atherosclerotic cardiovascular disease (ASCVD) reduce a high proportion of recurrent …

In this second part of a 2-part series on the global burden of cardiovascular disease, we
review the proven, effective approaches to the prevention and treatment of cardiovascular …

ABSTRACT Introduction: Cardiovascular diseases (CVDs) are chronic, heterogeneous
diseases which are generally classified according to clinical presentation. However, the …

The current incidence and prevalence of noncommunicable diseases (NCDs) is currently a
cause for great concern on a global scale; future projections are no less disconcerting …

Atherosclerotic cardiovascular disease (ASCVD) and its associated economic burden are
increasing globally. Although cardiac rehabilitation is a vital component of secondary …

The results from Folsom and colleagues' large longitudinal study not only reinforce the
effectiveness of primordial prevention, but they also support a renewed focus on the concept …

There are 3 critical pathways for preventing the development and progression of
cardiovascular disease (CVD): 1) primordial prevention, wherein the goal is to prevent the …